Out-licensing: Diagnostic/Supplies/Biological Materials

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 11..17 of 17 - per page Previous page
Order by

Modified Sugar Substrates and Methods of Use

Methods and compositions for making and using functionalized sugars More

Neutralizing Monoclonal Antibodies to Botulinum neurotoxin A

These chimpanzee-derived mAbs can be developed for prevention, therapy, or diagnosis of BoNT/A. More

Botulinum Toxoid

A variety of new toxoids useful as botulinum vaccine antigens, for BAT or BIG production, or for development of tests to evaluate antigenicity of botulinum vaccines More

Monoclonal Antibody for Lyme Disease Diagnostic and Research

This antibody can be used in diagnostic and research applications related to Lyme disease or other Borrelia-caused conditions. More

Diagnostic and Therapeutic Strategies for Metastatic Hepatocellular Carcinoma by Targeting Osteopontin

This technology identifies a 10 kD residue of osteopontin as a potential prognostic marker and therapeutic target for metastatic hepatocellular carcinoma (HCC). More

Multicolored Fluorescent Cell Lines for High-Throughput Angiogenesis and Cytotoxicity Screening

Immortalized cell lines that constitutively express different fluorescent proteins, in vitro angiogenesis assays, and a software application have been developed. More

Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax

Use of Shewanella CPS conjugates as a component of an anthrax vaccine More

Displaying 11..17 of 17 - per page Previous page
Order by

Your selection

Industry sector: Diagnostic del; Supplies del; Biological materials del

Browse By

Therapeutic target: Accident and Trauma; Allergy; Blood and forming organs; Cardiovascular; Central Nervous System; Dermatological; Endocrinology; Gastrointestinal; Genetic disorders; Genito-urinary; Hospital and Surgery; Immune related disorders; Infectious diseases; Metabolism; Musculoskeletal; Oncology; Oral Health; Other therapeutic; Respiratory; Sensory organ
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us